Proellex® - Endometriosis (ZPE-201): Safety and Efficacy Study to Evaluate Proellex® in the Treatment of Premenopausal Women with Symptomatic Endometriosis
Purpose: The purpose of this study is to determine whether Proellex® is safe and effective for the treatment of symptomatic endometriosis.
Proellex® - PK Bridging (ZP-002): Proellex® Pharmacokinetic Bridging Study II
Purpose: This is an open-label, randomized, single-center, outpatient, unblinded, single-dose, three-way crossover study of the safety and PK properties of Proellex® in women ages 18 - 34 years. Safety will be assessed throughout the study.
Proellex® - Safety and PK (ZP-003): A Safety and Pharmacokinetic (PK) Study of Proellex®
Purpose: This is an open-label, single-center, outpatient, unblinded, multi-dose study of the safety and pharmacokinetic properties of Proellex®. Safety will be assessed throughout the study.